Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 184 entries
Sorted by: Best Match Show Resources per page
Assessment of education and computerized decision support interventions for improving transfusion practice

education interventions

Rothschild JM.
GSID: WZWBIhUpYxcJ
JM Rothschild, S McGurk, M Honour, L Lu… - …, 2007 - Wiley Online Library

BACKGROUND: Overuse of blood products is common, but prior efforts to improve transfusion decisions have met with limited success. STUDY DESIGN AND METHODS: This study examines transfusion practices before and after a conventional educational intervention …

Cite
Rothschild, J. M., McGurk, S., Honour, M., Lu, L., McClendon, A. A., Srivastava, P., ... & Bates, D. W. (2007). Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion, 47(2), 228-239.
Rothschild, Jeffrey M., et al. "Assessment of education and computerized decision support interventions for improving transfusion practice." Transfusion 47.2 (2007): 228-239.
Copy Download .nbib Format: MLA
Health behaviors in nurse faculty: how healthy are we?.

Nurse educator

Ahijevych K, Rothschild S.
PMID: 3211387
Nurse Educ. 1988 Sep-Oct;13(5):6-7. doi: 10.1097/00006223-198809000-00006.

No abstract available.

Cite
Ahijevych K, Rothschild S. Health behaviors in nurse faculty: how healthy are we?. Nurse Educ. 1988;13(5):6-7doi: 10.1097/00006223-198809000-00006.
Ahijevych, K., & Rothschild, S. (1988). Health behaviors in nurse faculty: how healthy are we?. Nurse educator, 13(5), 6-7. https://doi.org/10.1097/00006223-198809000-00006
Ahijevych, K, and Rothschild, S. "Health behaviors in nurse faculty: how healthy are we?." Nurse educator vol. 13,5 (1988): 6-7. doi: https://doi.org/10.1097/00006223-198809000-00006
Ahijevych K, Rothschild S. Health behaviors in nurse faculty: how healthy are we?. Nurse Educ. 1988 Sep-Oct;13(5):6-7. doi: 10.1097/00006223-198809000-00006. PMID: 3211387.
Copy Download .nbib Format: NLM
Direction of MR imaging.

Investigative radiology

Rothschild PA, Crooks LE, Margulis AR.
PMID: 2185180
Invest Radiol. 1990 Mar;25(3):275-81. doi: 10.1097/00004424-199003000-00013.

No abstract available.

Cite
Rothschild PA, Crooks LE, Margulis AR. Direction of MR imaging. Invest Radiol. 1990;25(3):275-81doi: 10.1097/00004424-199003000-00013.
Rothschild, P. A., Crooks, L. E., & Margulis, A. R. (1990). Direction of MR imaging. Investigative radiology, 25(3), 275-81. https://doi.org/10.1097/00004424-199003000-00013
Rothschild, P A, et al. "Direction of MR imaging." Investigative radiology vol. 25,3 (1990): 275-81. doi: https://doi.org/10.1097/00004424-199003000-00013
Rothschild PA, Crooks LE, Margulis AR. Direction of MR imaging. Invest Radiol. 1990 Mar;25(3):275-81. doi: 10.1097/00004424-199003000-00013. PMID: 2185180.
Copy Download .nbib Format: NLM
Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy.

Journal for immunotherapy of cancer

Koelzer VH, Buser T, Willi N, Rothschild SI, Wicki A, Schiller P, Cathomas G, Zippelius A, Mertz KD.
PMID: 27532022
J Immunother Cancer. 2016 Aug 16;4:47. doi: 10.1186/s40425-016-0151-z. eCollection 2016.

BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 receptor (PD-1) or PD ligand 1 (PD-L1). Skin toxicity most commonly includes a maculopapular erythematous rash...

Cite
Koelzer VH, Buser T, Willi N, et al. Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy. J Immunother Cancer. 2016;4:47doi: 10.1186/s40425-016-0151-z.
Koelzer, V. H., Buser, T., Willi, N., Rothschild, S. I., Wicki, A., Schiller, P., Cathomas, G., Zippelius, A., & Mertz, K. D. (2016). Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy. Journal for immunotherapy of cancer, 447. https://doi.org/10.1186/s40425-016-0151-z
Koelzer, Viktor H, et al. "Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy." Journal for immunotherapy of cancer vol. 4 (2016): 47. doi: https://doi.org/10.1186/s40425-016-0151-z
Koelzer VH, Buser T, Willi N, Rothschild SI, Wicki A, Schiller P, Cathomas G, Zippelius A, Mertz KD. Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy. J Immunother Cancer. 2016 Aug 16;4:47. doi: 10.1186/s40425-016-0151-z. eCollection 2016. PMID: 27532022; PMCID: PMC4986338.
Copy Download .nbib Format: NLM
Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience.

Journal of Cancer

Hagmann R, Hess V, Zippelius A, Rothschild SI.
PMID: 26516363
J Cancer. 2015 Sep 15;6(11):1148-54. doi: 10.7150/jca.13080. eCollection 2015.

BACKGROUND: Randomized trials established topotecan and the combination of adriamycin, cyclophosphamide and vincristine (ACO) as second-line therapy options for small-cell lung cancer. We retrospectively evaluated the outcome of SCLC patients undergoing second-line chemotherapy.PATIENTS AND METHODS: 92 consecutive patients with...

Cite
Hagmann R, Hess V, Zippelius A, et al. Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience. J Cancer. 2015;6(11):1148-54doi: 10.7150/jca.13080.
Hagmann, R., Hess, V., Zippelius, A., & Rothschild, S. I. (2015). Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience. Journal of Cancer, 6(11), 1148-54. https://doi.org/10.7150/jca.13080
Hagmann, Raphael, et al. "Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience." Journal of Cancer vol. 6,11 (2015): 1148-54. doi: https://doi.org/10.7150/jca.13080
Hagmann R, Hess V, Zippelius A, Rothschild SI. Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience. J Cancer. 2015 Sep 15;6(11):1148-54. doi: 10.7150/jca.13080. eCollection 2015. PMID: 26516363; PMCID: PMC4615351.
Copy Download .nbib Format: NLM
Genomic adaptation of admixed dairy cattle in East Africa.

Frontiers in genetics

Kim ES, Rothschild MF.
PMID: 25566325
Front Genet. 2014 Dec 19;5:443. doi: 10.3389/fgene.2014.00443. eCollection 2014.

Dairy cattle in East Africa imported from the U.S. and Europe have been adapted to new environments. In small local farms, cattle have generally been maintained by crossbreeding that could increase survivability under a severe environment. Eventually, genomic ancestry...

Cite
Kim ES, Rothschild MF. Genomic adaptation of admixed dairy cattle in East Africa. Front Genet. 2014;5:443doi: 10.3389/fgene.2014.00443.
Kim, E. S., & Rothschild, M. F. (2014). Genomic adaptation of admixed dairy cattle in East Africa. Frontiers in genetics, 5443. https://doi.org/10.3389/fgene.2014.00443
Kim, Eui-Soo, and Rothschild, Max F. "Genomic adaptation of admixed dairy cattle in East Africa." Frontiers in genetics vol. 5 (2014): 443. doi: https://doi.org/10.3389/fgene.2014.00443
Kim ES, Rothschild MF. Genomic adaptation of admixed dairy cattle in East Africa. Front Genet. 2014 Dec 19;5:443. doi: 10.3389/fgene.2014.00443. eCollection 2014. PMID: 25566325; PMCID: PMC4271701.
Copy Download .nbib Format: NLM
Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK.

Cancers

Rothschild SI.
PMID: 26018876
Cancers (Basel). 2015 May 26;7(2):930-49. doi: 10.3390/cancers7020816.

Systemic therapy for non-small cell lung cancer (NSCLC) has undergone a dramatic paradigm shift over the past decade. Advances in our understanding of the underlying biology of NSCLC have revealed distinct molecular subtypes. A substantial proportion of NSCLC depends...

Cite
Rothschild SI. Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK. Cancers (Basel). 2015;7(2):930-49doi: 10.3390/cancers7020816.
Rothschild, S. I. (2015). Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK. Cancers, 7(2), 930-49. https://doi.org/10.3390/cancers7020816
Rothschild, Sacha I. "Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK." Cancers vol. 7,2 (2015): 930-49. doi: https://doi.org/10.3390/cancers7020816
Rothschild SI. Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK. Cancers (Basel). 2015 May 26;7(2):930-49. doi: 10.3390/cancers7020816. PMID: 26018876; PMCID: PMC4491691.
Copy Download .nbib Format: NLM
Erratum to: The Valdostana goat: a genome-wide investigation of the distinctiveness of its selective sweep regions.

Mammalian genome : official journal of the International Mammalian Genome Society

Talenti A, Bertolini F, Pagnacco G, Pilla F, Ajmone-Marsan P, Rothschild MF, Crepaldi P.
PMID: 28303291
Mamm Genome. 2017 Apr;28(3):129. doi: 10.1007/s00335-017-9685-8.

No abstract available.

Cite
Talenti A, Bertolini F, Pagnacco G, et al. Erratum to: The Valdostana goat: a genome-wide investigation of the distinctiveness of its selective sweep regions. Mamm Genome. 2017;28(3):129doi: 10.1007/s00335-017-9685-8.
Talenti, A., Bertolini, F., Pagnacco, G., Pilla, F., Ajmone-Marsan, P., Rothschild, M. F., Crepaldi, P. (2017). Erratum to: The Valdostana goat: a genome-wide investigation of the distinctiveness of its selective sweep regions. Mammalian genome : official journal of the International Mammalian Genome Society, 28(3), 129. https://doi.org/10.1007/s00335-017-9685-8
Talenti, Andrea, et al. "Erratum to: The Valdostana goat: a genome-wide investigation of the distinctiveness of its selective sweep regions." Mammalian genome : official journal of the International Mammalian Genome Society vol. 28,3 (2017): 129. doi: https://doi.org/10.1007/s00335-017-9685-8
Talenti A, Bertolini F, Pagnacco G, Pilla F, Ajmone-Marsan P, Rothschild MF, Crepaldi P. Erratum to: The Valdostana goat: a genome-wide investigation of the distinctiveness of its selective sweep regions. Mamm Genome. 2017 Apr;28(3):129. doi: 10.1007/s00335-017-9685-8. PMID: 28303291.
Copy Download .nbib Format: NLM
Differential diagnosis of deep gluteal pain in a female runner with pelvic involvement: a case report.

International journal of sports physical therapy

Podschun L, Hanney WJ, Kolber MJ, Garcia A, Rothschild CE.
PMID: 24175132
Int J Sports Phys Ther. 2013 Aug;8(4):462-71.

BACKGROUND: Gluteal injuries, proximal hamstring injuries, and pelvic floor disorders have been reported in the literature among runners. Some suggest that hip, pelvis, and/or groin injuries occur in 3.3% to 11.5% of long distance runners. The purpose of this...

Cite
Podschun L, Hanney WJ, Kolber MJ, et al. Differential diagnosis of deep gluteal pain in a female runner with pelvic involvement: a case report. Int J Sports Phys Ther. 2013;8(4):462-71
Podschun, L., Hanney, W. J., Kolber, M. J., Garcia, A., & Rothschild, C. E. (2013). Differential diagnosis of deep gluteal pain in a female runner with pelvic involvement: a case report. International journal of sports physical therapy, 8(4), 462-71.
Podschun, Laura, et al. "Differential diagnosis of deep gluteal pain in a female runner with pelvic involvement: a case report." International journal of sports physical therapy vol. 8,4 (2013): 462-71.
Podschun L, Hanney WJ, Kolber MJ, Garcia A, Rothschild CE. Differential diagnosis of deep gluteal pain in a female runner with pelvic involvement: a case report. Int J Sports Phys Ther. 2013 Aug;8(4):462-71. PMID: 24175132; PMCID: PMC3812833.
Copy Download .nbib Format: NLM
The effect of dextroamphetamine on habituation of peripheral vascular response in children.

Journal of abnormal child psychology

Conners CK, Rothschild GH.
PMID: 24198128
J Abnorm Child Psychol. 1973 Jan;1(1):16-25. doi: 10.1007/BF00917887.

The blood volume pulse (BVP) measured by a photoplethysmograph was recorded in 43 children with behavior and learning problems before and after either stimulant drug treatment or placebo. A series of twenty-four 750-cps tones was presented at 10-sec. intervals,...

Cite
Conners CK, Rothschild GH. The effect of dextroamphetamine on habituation of peripheral vascular response in children. J Abnorm Child Psychol. 1973;1(1):16-25doi: 10.1007/BF00917887.
Conners, C. K., & Rothschild, G. H. (1973). The effect of dextroamphetamine on habituation of peripheral vascular response in children. Journal of abnormal child psychology, 1(1), 16-25. https://doi.org/10.1007/BF00917887
Conners, C K, and Rothschild, G H. "The effect of dextroamphetamine on habituation of peripheral vascular response in children." Journal of abnormal child psychology vol. 1,1 (1973): 16-25. doi: https://doi.org/10.1007/BF00917887
Conners CK, Rothschild GH. The effect of dextroamphetamine on habituation of peripheral vascular response in children. J Abnorm Child Psychol. 1973 Jan;1(1):16-25. doi: 10.1007/BF00917887. PMID: 24198128.
Copy Download .nbib Format: NLM
New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib.

Therapeutics and clinical risk management

Rothschild SI.
PMID: 27217763
Ther Clin Risk Manag. 2016 May 05;12:735-41. doi: 10.2147/TCRM.S87876. eCollection 2016.

Rearrangements in ALK gene and EML4 gene were first described in 2007. This genomic aberration is found in about 2%-8% of non-small-cell lung cancer (NSCLC) patients. Crizotinib was the first ALK tyrosine kinase inhibitor licensed for the treatment of...

Cite
Rothschild SI. New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib. Ther Clin Risk Manag. 2016;12:735-41doi: 10.2147/TCRM.S87876.
Rothschild, S. I. (2016). New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib. Therapeutics and clinical risk management, 12735-41. https://doi.org/10.2147/TCRM.S87876
Rothschild, Sacha I. "New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib." Therapeutics and clinical risk management vol. 12 (2016): 735-41. doi: https://doi.org/10.2147/TCRM.S87876
Rothschild SI. New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib. Ther Clin Risk Manag. 2016 May 05;12:735-41. doi: 10.2147/TCRM.S87876. eCollection 2016. PMID: 27217763; PMCID: PMC4863587.
Copy Download .nbib Format: NLM
THE CONTRARIETIES OF PSYCHIATRIC THEORY AND A WAY TO THEIR RESOLUTION.

The Israel annals of psychiatry and related disciplines

ROTHSCHILD FS.
PMID: 14300957
Isr Ann Psychiatr Relat Discip. 1965 Apr;3:1-23.

No abstract available.

Cite
ROTHSCHILD FS. THE CONTRARIETIES OF PSYCHIATRIC THEORY AND A WAY TO THEIR RESOLUTION. Isr Ann Psychiatr Relat Discip. 1965;3:1-23
ROTHSCHILD, F. S. (1965). THE CONTRARIETIES OF PSYCHIATRIC THEORY AND A WAY TO THEIR RESOLUTION. The Israel annals of psychiatry and related disciplines, 31-23.
ROTHSCHILD, F S. "THE CONTRARIETIES OF PSYCHIATRIC THEORY AND A WAY TO THEIR RESOLUTION." The Israel annals of psychiatry and related disciplines vol. 3 (1965): 1-23.
ROTHSCHILD FS. THE CONTRARIETIES OF PSYCHIATRIC THEORY AND A WAY TO THEIR RESOLUTION. Isr Ann Psychiatr Relat Discip. 1965 Apr;3:1-23. PMID: 14300957.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 184 entries